Drug information for MUCINEX D

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET, EXTENDED RELEASE; ORAL 1.2GM;120MG Over The Counter  (Reference Drug) GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE Guaifenesin RECKITT BENCKISER 21585
2010-12-22 Letter
2007-09-07 Label
2007-09-07 Letter
2005-12-01 Review
2005-03-03 Letter
2005-01-26 Letter
2004-06-25 Letter
2004-06-25 Label
TABLET, EXTENDED RELEASE; ORAL 600MG;60MG Over The Counter   GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE Guaifenesin RECKITT BENCKISER   "

Drug Adverse Effects information for MUCINEX D

Role code Indications Reaction # Reports
PS NASOPHARYNGITIS ATRIAL FIBRILLATION 2
PS NASOPHARYNGITIS CARDIAC DISORDER 2
PS PRODUCT USED FOR UNKNOWN INDICATION ATRIAL FIBRILLATION 2
PS PRODUCT USED FOR UNKNOWN INDICATION BLOOD PRESSURE INCREASED 3
PS PRODUCT USED FOR UNKNOWN INDICATION CARDIAC DISORDER 2
PS PRODUCT USED FOR UNKNOWN INDICATION DIZZINESS 1
PS PRODUCT USED FOR UNKNOWN INDICATION EPISTAXIS 1
PS PRODUCT USED FOR UNKNOWN INDICATION HAEMATOCHEZIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION HALLUCINATION 1
PS PRODUCT USED FOR UNKNOWN INDICATION HEADACHE 2
PS PRODUCT USED FOR UNKNOWN INDICATION HEART RATE INCREASED 2
PS PRODUCT USED FOR UNKNOWN INDICATION INCORRECT DRUG ADMINISTRATION DURATION 1
PS PRODUCT USED FOR UNKNOWN INDICATION PALPITATIONS 1
SS PRODUCT USED FOR UNKNOWN INDICATION HAEMOPTYSIS 2
SS PRODUCT USED FOR UNKNOWN INDICATION INSOMNIA 2
C ASTHMA ANOSMIA 1
C ASTHMA BACK PAIN 1
C ASTHMA CHEST PAIN 1
C ASTHMA DIVERTICULITIS 1
C ASTHMA DYSPHONIA 1
C ASTHMA TONGUE DISCOLOURATION 1
C ASTHMA WEIGHT DECREASED 1
C CONTRACEPTION CD4 LYMPHOCYTES DECREASED 1
C CONTRACEPTION CD8 LYMPHOCYTES DECREASED 1
C CONTRACEPTION CERVICAL DYSPLASIA 3
C CONTRACEPTION LYMPHOCYTE COUNT DECREASED 1
C CONTRACEPTION VULVAL CANCER STAGE 0 3
C CONTRACEPTION VULVAR DYSPLASIA 3
C CONTRACEPTION VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 1
C COUGH CD4 LYMPHOCYTES DECREASED 1
C COUGH CD8 LYMPHOCYTES DECREASED 1
C COUGH CERVICAL DYSPLASIA 3
C COUGH LYMPHOCYTE COUNT DECREASED 1
C COUGH VULVAL CANCER STAGE 0 3
C COUGH VULVAR DYSPLASIA 3
C COUGH VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 1
C DIFFUSE LARGE B-CELL LYMPHOMA ANAEMIA 2
C DIFFUSE LARGE B-CELL LYMPHOMA FATIGUE 2
C DIFFUSE LARGE B-CELL LYMPHOMA HYPERTENSION 2
C DIFFUSE LARGE B-CELL LYMPHOMA LUNG INFECTION 2
C DIFFUSE LARGE B-CELL LYMPHOMA MAXILLOFACIAL SINUS NEOPLASM 2
C DIFFUSE LARGE B-CELL LYMPHOMA MENTAL STATUS CHANGES 2
C DIFFUSE LARGE B-CELL LYMPHOMA NEOPLASM MALIGNANT 2
C DIFFUSE LARGE B-CELL LYMPHOMA NEOPLASM PROGRESSION 2
C DIFFUSE LARGE B-CELL LYMPHOMA SOMNOLENCE 2
C DIFFUSE LARGE B-CELL LYMPHOMA THROMBOCYTOPENIA 2
C HYPERTENSION ASTHENIA 1
C HYPERTENSION BALANCE DISORDER 1
C HYPERTENSION DEHYDRATION 1
C HYPERTENSION DIVERTICULUM 1
C HYPERTENSION FALL 1
C HYPERTENSION GASTROENTERITIS 1
C HYPERTENSION HEADACHE 1
C HYPERTENSION HYPERTENSION 1
C HYPERTENSION HYPOAESTHESIA 1
C HYPERTENSION INJECTION SITE ERYTHEMA 1
C HYPERTENSION JOINT SWELLING 1
C HYPERTENSION PARAESTHESIA 1
C HYPERTENSION RENAL FAILURE ACUTE 1
C HYPERTENSION RENAL TUBULAR NECROSIS 1
C MEDICAL DIET CD4 LYMPHOCYTES DECREASED 1
C MEDICAL DIET CD8 LYMPHOCYTES DECREASED 1
C MEDICAL DIET CERVICAL DYSPLASIA 3
C MEDICAL DIET LYMPHOCYTE COUNT DECREASED 1
C MEDICAL DIET VULVAL CANCER STAGE 0 3
C MEDICAL DIET VULVAR DYSPLASIA 3
C MEDICAL DIET VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 1
C MULTIPLE SCLEROSIS ASTHENIA 1
C MULTIPLE SCLEROSIS BALANCE DISORDER 1
C MULTIPLE SCLEROSIS CD4 LYMPHOCYTES DECREASED 2
C MULTIPLE SCLEROSIS CD8 LYMPHOCYTES DECREASED 2
C MULTIPLE SCLEROSIS CERVICAL DYSPLASIA 6
C MULTIPLE SCLEROSIS DEHYDRATION 1
C MULTIPLE SCLEROSIS DIVERTICULUM 1
C MULTIPLE SCLEROSIS FALL 1
C MULTIPLE SCLEROSIS GASTROENTERITIS 1
C MULTIPLE SCLEROSIS HEADACHE 1
C MULTIPLE SCLEROSIS HYPERTENSION 1
C MULTIPLE SCLEROSIS HYPOAESTHESIA 1
C MULTIPLE SCLEROSIS INJECTION SITE ERYTHEMA 1
C MULTIPLE SCLEROSIS JOINT SWELLING 1
C MULTIPLE SCLEROSIS LYMPHOCYTE COUNT DECREASED 2
C MULTIPLE SCLEROSIS PARAESTHESIA 1
C MULTIPLE SCLEROSIS RENAL FAILURE ACUTE 1
C MULTIPLE SCLEROSIS RENAL TUBULAR NECROSIS 1
C MULTIPLE SCLEROSIS VULVAL CANCER STAGE 0 6
C MULTIPLE SCLEROSIS VULVAR DYSPLASIA 6
C MULTIPLE SCLEROSIS VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 2
C MULTIPLE SCLEROSIS RELAPSE CD4 LYMPHOCYTES DECREASED 1
C MULTIPLE SCLEROSIS RELAPSE CD8 LYMPHOCYTES DECREASED 1
C MULTIPLE SCLEROSIS RELAPSE CERVICAL DYSPLASIA 3
C MULTIPLE SCLEROSIS RELAPSE LYMPHOCYTE COUNT DECREASED 1
C MULTIPLE SCLEROSIS RELAPSE VULVAL CANCER STAGE 0 3
C MULTIPLE SCLEROSIS RELAPSE VULVAR DYSPLASIA 3
C MULTIPLE SCLEROSIS RELAPSE VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 1
C MYCOBACTERIUM AVIUM COMPLEX INFECTION ANOSMIA 7
C MYCOBACTERIUM AVIUM COMPLEX INFECTION BACK PAIN 7
C MYCOBACTERIUM AVIUM COMPLEX INFECTION CHEST PAIN 7
C MYCOBACTERIUM AVIUM COMPLEX INFECTION DIVERTICULITIS 7
C MYCOBACTERIUM AVIUM COMPLEX INFECTION DYSPHONIA 7
C MYCOBACTERIUM AVIUM COMPLEX INFECTION TONGUE DISCOLOURATION 7
C MYCOBACTERIUM AVIUM COMPLEX INFECTION WEIGHT DECREASED 7
C PAIN CD4 LYMPHOCYTES DECREASED 1
C PAIN CD8 LYMPHOCYTES DECREASED 1
C PAIN CERVICAL DYSPLASIA 3
C PAIN LYMPHOCYTE COUNT DECREASED 1
C PAIN VULVAL CANCER STAGE 0 3
C PAIN VULVAR DYSPLASIA 3
C PAIN VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 1
C PREMEDICATION ASTHENIA 1
C PREMEDICATION BALANCE DISORDER 1
C PREMEDICATION DEHYDRATION 1
C PREMEDICATION DIVERTICULUM 1
C PREMEDICATION FALL 1
C PREMEDICATION GASTROENTERITIS 1
C PREMEDICATION HEADACHE 1
C PREMEDICATION HYPERTENSION 1
C PREMEDICATION HYPOAESTHESIA 1
C PREMEDICATION INJECTION SITE ERYTHEMA 1
C PREMEDICATION JOINT SWELLING 1
C PREMEDICATION PARAESTHESIA 1
C PREMEDICATION RENAL FAILURE ACUTE 1
C PREMEDICATION RENAL TUBULAR NECROSIS 1
C PRODUCT USED FOR UNKNOWN INDICATION CD4 LYMPHOCYTES DECREASED 3
C PRODUCT USED FOR UNKNOWN INDICATION CD8 LYMPHOCYTES DECREASED 3
C PRODUCT USED FOR UNKNOWN INDICATION CERVICAL DYSPLASIA 9
C PRODUCT USED FOR UNKNOWN INDICATION LYMPHOCYTE COUNT DECREASED 3
C PRODUCT USED FOR UNKNOWN INDICATION VULVAL CANCER STAGE 0 9
C PRODUCT USED FOR UNKNOWN INDICATION VULVAR DYSPLASIA 9
C PRODUCT USED FOR UNKNOWN INDICATION VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 3
C RESPIRATORY TRACT CONGESTION CD4 LYMPHOCYTES DECREASED 2
C RESPIRATORY TRACT CONGESTION CD8 LYMPHOCYTES DECREASED 2
C RESPIRATORY TRACT CONGESTION CERVICAL DYSPLASIA 6
C RESPIRATORY TRACT CONGESTION LYMPHOCYTE COUNT DECREASED 2
C RESPIRATORY TRACT CONGESTION VULVAL CANCER STAGE 0 6
C RESPIRATORY TRACT CONGESTION VULVAR DYSPLASIA 6
C RESPIRATORY TRACT CONGESTION VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 2
C RESPIRATORY TRACT INFECTION CD4 LYMPHOCYTES DECREASED 1
C RESPIRATORY TRACT INFECTION CD8 LYMPHOCYTES DECREASED 1
C RESPIRATORY TRACT INFECTION CERVICAL DYSPLASIA 3
C RESPIRATORY TRACT INFECTION LYMPHOCYTE COUNT DECREASED 1
C RESPIRATORY TRACT INFECTION VULVAL CANCER STAGE 0 3
C RESPIRATORY TRACT INFECTION VULVAR DYSPLASIA 3
C RESPIRATORY TRACT INFECTION VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 1
C RHEUMATOID ARTHRITIS NASOPHARYNGITIS 1
C RHEUMATOID ARTHRITIS PRURITUS 1
C THYROID CANCER AMNESIA 2
C THYROID CANCER ARTHRALGIA 2
C THYROID CANCER BACK PAIN 2
C THYROID CANCER BLOOD CALCITONIN INCREASED 2
C THYROID CANCER BLOOD THYROID STIMULATING HORMONE INCREASED 2
C THYROID CANCER CONFUSIONAL STATE 2
C THYROID CANCER CONTUSION 3
C THYROID CANCER DIARRHOEA 2
C THYROID CANCER DYSPHEMIA 3
C THYROID CANCER ELECTROCARDIOGRAM QT PROLONGED 2
C THYROID CANCER FAECAL INCONTINENCE 2
C THYROID CANCER FALL 2
C THYROID CANCER FATIGUE 2
C THYROID CANCER GAIT DISTURBANCE 2
C THYROID CANCER GASTROOESOPHAGEAL REFLUX DISEASE 3
C THYROID CANCER HAEMANGIOMA OF LIVER 2
C THYROID CANCER HAND FRACTURE 3
C THYROID CANCER HEAD AND NECK CANCER 2
C THYROID CANCER HEAD AND NECK CANCER STAGE III 2
C THYROID CANCER HEPATIC LESION 3
C THYROID CANCER HYPOTHYROIDISM 2
C THYROID CANCER INCORRECT DOSE ADMINISTERED 2
C THYROID CANCER MEMORY IMPAIRMENT 3
C THYROID CANCER MENTAL STATUS CHANGES 2
C THYROID CANCER METABOLIC ENCEPHALOPATHY 3
C THYROID CANCER METASTASES TO BONE 3
C THYROID CANCER METASTASES TO BONE MARROW 2
C THYROID CANCER MUSCULAR WEAKNESS 2
C THYROID CANCER NAUSEA 2
C THYROID CANCER NERVOUSNESS 2
C THYROID CANCER OSTEOLYSIS 3
C THYROID CANCER PARAESTHESIA 2
C THYROID CANCER RESTLESSNESS 2
C THYROID CANCER SEROMA 2
C THYROID CANCER SPINAL COLUMN STENOSIS 3
C THYROID CANCER SPINAL CORD COMPRESSION 2
C THYROID CANCER THYROID CANCER 3
C THYROID CANCER THYROID CANCER METASTATIC 2
C THYROID CANCER TRACHEAL STENOSIS 3
C THYROID CANCER URINARY INCONTINENCE 2
C URINARY TRACT INFECTION CD4 LYMPHOCYTES DECREASED 2
C URINARY TRACT INFECTION CD8 LYMPHOCYTES DECREASED 2
C URINARY TRACT INFECTION CERVICAL DYSPLASIA 6
C URINARY TRACT INFECTION LYMPHOCYTE COUNT DECREASED 2
C URINARY TRACT INFECTION VULVAL CANCER STAGE 0 6
C URINARY TRACT INFECTION VULVAR DYSPLASIA 6
C URINARY TRACT INFECTION VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 2
C VITAMIN SUPPLEMENTATION CD4 LYMPHOCYTES DECREASED 1
C VITAMIN SUPPLEMENTATION CD8 LYMPHOCYTES DECREASED 1
C VITAMIN SUPPLEMENTATION CERVICAL DYSPLASIA 3
C VITAMIN SUPPLEMENTATION LYMPHOCYTE COUNT DECREASED 1
C VITAMIN SUPPLEMENTATION VULVAL CANCER STAGE 0 3
C VITAMIN SUPPLEMENTATION VULVAR DYSPLASIA 3
C VITAMIN SUPPLEMENTATION VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION 1
Ads by Google